Arcutis Biotherapeutics Inc. has granted a total of 94,000 restricted stock units of its common stock to 12 newly hired employees. These awards, granted under the Arcutis Biotherapeutics, Inc. 2022 Inducement Plan with a grant date of February 2, 2026, will vest over four years, with 25 percent vesting on each annual anniversary of the vesting commencement date, provided the employee remains continuously employed by Arcutis.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9649284) on February 05, 2026, and is solely responsible for the information contained therein.